Skip to main content

Over halfway in the recruitment of Picasso

Two women

An important milestone is reached in the Picasso study, which is the largest of its kind. Over 200 participants are now included - and with that the project is well over halfway in goal with the inclusion. The study compares different treatments in painful osteoarthritis in the root of the thumb.

- This is a very good news. We have gained good speed in the recruitment and see that the collaboration between the hospitals works well, says project manager Ida K. Bos-Haugen, chief physician at Diakonhjemmet Hospital.

Three treatments

The Picasso study is a randomized controlled multi-center study in which researchers examine the effect of three different treatments for osteoarthritis in the root of the thumb: cortisone injection, saltwater injection (placebo) and a targeted occupational therapy offer.

A total of 354 people will be included, and the first 200 are now included.

- We would like to thank both the participants and everyone who contributes with recruitment and implementation. There is a great deal of work behind these figures, says Marthe Gløersen, doctor and postdoctoral fellow at Diakonhjemmet Hospital.

Six hospitals participate

The study is led from Remedy - research center for musculoskeletal health at Diakonhjemmet Hospital, but also recruits participants from:

  • Martina Hansen's Hospital
  • Haugesund Sanitetsforening Rheumatism Hospital
  • Stavanger University Hospital
  • St. Olavs Hospital
  • Nordland Hospital in Bodø

 

-This is one of the biggest treatment studies on osteoarthritis in Norway, and we hope the results will benefit both patients and clinicians, says Bos-Haugen.

The Picasso study is open to people with pain in the root of the thumb who have not recently received injection treatment. The treatment takes place after a draw, and the participants are followed up closely for 6 months and with a final control after 2 years.

Want to know more?

Read more about Picasso on our website!